NDC 0049-2340-79 - Relpax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0049-2340
- Requested NDC
- 0049-2340-79
- Package NDCs from labels
- 0049-2340-79, 0049-2340-45, 0049-2340-05
- Manufacturer
- ROERIG
- Effective date
- 2020-03-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Relpax - ROERIG | ROERIG | 2020-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Relpax - STAT Rx USA LLC | PSS World Medical Inc | STAT Rx USA LLC | PSS World Medical Inc | 2012-08-13 | HUMAN PRESCRIPTION DRUG LABEL |
| RELPAX® (eletriptan hydrobromide) Tablets | Physicians Total Care, Inc. | 2012-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Relpax - Rebel Distributors Corp | Rebel Distributors Corp | 2010-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0049-2340-05 | Relpax | 12 in 1 CARTON | TABLET, FILM COATED | 12 | 25 | |
| 0049-2340-45 | Relpax | 6 in 1 CARTON | TABLET, FILM COATED | 6 | 25 | |
| 0049-2340-79 | Relpax | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 25 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0049-2340-05 | EA - Each | 0049-2340 | 8e19521a-06b4-449a-96e1-63baa1b02fb4 | 1 | 2013-02-13 |
| 0049-2340-45 | EA - Each | 0049-2340 | 65680d40-b683-447c-86a3-ae88a6273e61 | 1 | 2012-07-24 |
| 0049-2340-79 | EA - Each | 0049-2340 | 9fc635b3-42ab-4654-b3df-2d78299140ed | 1 | 2016-07-19 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.